ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. JCR Adds $825m Gene Therapy Tech D
Pink SheetMSN Laboratories’ US Food and Drug Administration approval for its generic version of Novartis’ multi-billion-dollar heart failure drug Entresto (sacubitril/valsartan) has been stayed for now by a Wa
Pink SheetNovartis AG has swiftly filed suit against the US Food and Drug Administration after the agency’s denial of a second citizen petition opened the door for what the Swiss originator company claims is a
Generics BulletinUS suitability petitions may be seeing renewed interest from sponsors following a surge of filings after the introduction of goal dates in October and then a drop-off of submissions after that. Nimish